Latest Materials News

Argent Minerals has pushed silver mineralisation beyond the current Kempfield Lode 100 resource boundary with a broad 91.2m intercept from near surface, highlighting significant potential for resource growth and mine development optionality.

Charger Metals has extended spodumene mineralisation at its Medcalf deposit to 700 metres depth, prompting a pending resource upgrade beyond the maiden 8.2Mt @ 1.0% Li2O estimate.

Anson Resources and POSCO Holdings have sealed a binding deal for a $7.2 million lithium extraction demonstration plant at Green River, advancing the project from concept to operational validation.

Paladin Energy Ltd (ASX:PDN) swung to a quarterly profit with US$8.4 million gross profit and bolstered its balance sheet through a A$400 million equity raise, positioning itself for expansion in uranium production and development.

Elevra Lithium has raised A$275 million through a fully underwritten institutional placement to fund its North American Lithium expansion and Moblan project development, supported by strong institutional demand.

Legacy Minerals has received NSW Government approvals for an 8,000m diamond drilling campaign at its Mt Carrington Project, targeting promising extensions at Mascotte and first-ever modern testing at the Emu copper-gold prospect.

Li-S Energy has secured vital approvals to airfreight lithium-sulfur prototype cells to the United States, paving the way for direct engagement with US defence and drone sectors.

Element 25 is making steady progress on its Butcherbird Expansion Project in Western Australia, with major equipment ordered, key contracts nearing finalisation, and project financing advancing toward closure ahead of a Q1 2027 commissioning target.

Equus Energy’s Pre-FEED study confirms the technical and commercial viability of its North West Shelf gas project, leveraging existing infrastructure to reduce costs and execution risks while targeting both LNG export and WA domestic gas markets.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

Brookside Energy has captured over 40% of its targeted Riverbend acreage in Oklahoma, advancing its development plans to expand its Anadarko Basin footprint and drilling inventory.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.